While reduced insulin sensitivity is a key metabolic disturbance linked to MASLD37,38, a large retrospective cohort study has underscored that a history of GDM, independent of insulin resistance or diabetes, constitutes an independent risk factor for the development of MASLD36. Here, INS is linked to Insulin resistance.